Notice to Clarify NIBIB's Research Objectives Under PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"

Notice Number: NOT-EB-19-002

Key Dates
Release Date:January 28, 2019

Related Announcements

PAR-19-134


Issued by
National Institute of Biomedical Imaging and Bioengineering (
NIBIB)

Purpose

The purpose of this Notice is to clarify NIBIB's research objectives under the Funding Opportunity Announcement (FOA) PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)". This Notice is providing additional information to:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Research Objectives of Participating NIH Institutes and Centers

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

The mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to improve human health by supporting the development of cutting-edge technologies and computational methods in Biomedical imaging and Bioengineering. NIBIB-funded innovations have broad impact and fundamentally change our ability to prevent, diagnose, and treat human disease. Under this FOA, NIBIB will fund research projects that can be generalized to multiple conditions and physiological contexts and that fall under one or more of its Scientific Program Areas.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Zeynep Erim, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4797
Email: erimz@mail.nih.gov